Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma.

Technology in cancer research & treatment - 1 Jan 2000

Du Feng, Dong Dezuo, Zhang Xiaodong, Jia Jun

Abstract excerpt

Background: Identification of novel biomarkers is crucial for the diagnosis and treatment of esophageal squamous cell carcinoma (ESCC). This study aimed to reveal the clinical significance and molecular characteristics of MYC-associated factor X dimerization protein 1 (MXD1) in ESCC. Patients and methods: We collected 3 ESCC cohorts to investigate the effect of MXD1 on clinical outcomes. In addition, we compared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Share to Databases, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to Esophageal Squamous Cell Carcinoma

Share to Neoplasm Staging

Share to Proportional Hazards Models

Share to Survival Analysis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34761715
DOI: 10.1177/15330338211052142
PMCID: PMC8591776

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma.PMID 34761715Read ↗

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer typesSemantic proximity Read ↗

Neoadjuvant therapy-associated malignant phenotype score predicts prognosis and highlights the roles of MIF signaling and DUXAP8 in ESCC.Semantic proximity Read ↗

Contribution of CMA1 to Esophageal Cancer Immunotherapy and PrognosisSemantic proximity Read ↗

Research on the Expression and Mechanism of LRRC8D in Esophageal Squamous Cell CarcinomaSemantic proximity Read ↗

The Clinical Significance of Forkhead Box M1 in Esophageal Squamous Cell Carcinoma Tissues: A Study Based on In-house Immunohistochemistry, RNA-sequencing, and Data MiningSemantic proximity Read ↗

A Potential Prognosis and Immune Biomarker in Cancer: DICER1Semantic proximity Read ↗

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)Semantic proximity Read ↗

The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma.Semantic proximity Read ↗

HSPD1 is a biomarker related to poor prognosis and tumor immune microenvironment in Head and Neck Squamous Cell Carcinoma by Bioinformatics and Cancer Database AnalysisSemantic proximity Read ↗

Investigating DOCK9 as a Potential Prognostic Marker: Implications for Angiogenesis and Immunity in Esophageal Squamous Cell CarcinomaSemantic proximity Read ↗

Potential association of HSPD1 with dysregulations in ribosome biogenesis and immune cell infiltration in lung adenocarcinoma: An integrated bioinformatic approachSemantic proximity Read ↗

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor typesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.